Prana Biotechnology Ltd

(PRNAF)

By |

Profile

Prana Biotechnology Ltd is active in the healthcare domain. The company is engaged in research collaboration with Takeda for the treatment of Parkinson's disease gastrointestinal neuropathology. The company's lead drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has also advanced a drug candidate for Parkinson's disease and other movement disorders (PBT434) and brain cancer (PBT519), which are in pre-clinical toxicology testing.

Contact Information

Website: www.pranabio.com
Email: info@pranabio.com
Main Phone: +61 393494906
Address: 460 Bourke Street
Address 2: Level 3
State: VIC
City / Town: Melbourne
Country: AUS
Postal Code: 3000

Issuer Information

Exchange: OTO
CEO: Geoffrey P. Kempler
Employees: 14
$ 0.03 $ 0. (0.00%)
Last Price 0.03 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close 0.03
Last Trade Volume 0 52 Wk Hi 0.051 52 Wk Low 0.0201
Market Cap 16.1 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 536,975,050.00 EPS (TTM) -0.01 PE Ratio N/A Exchange OTCPK